Tuesday, February 07, 2012

Posts Tagged ‘Policy’

Stem Cell Challenges in Biology and Public Policy

Douglas Melton, Professor of the Natural Sciences, Harvard University (April 10, 2007 at Princeton University) Description: Douglas Melton discusses the biology and public policy challenges surrounding stem cell research. The potential of human embryonic stem cells for understanding human development and finding new therapies will be presented. Dr. Melton is a cell and molecular biologist as well as an advocate of embryonic stem cell research. His research focuses on the developmental biology of the pancreas. One of the primary goals of his work is to understand how human embryonic stem cells differentiate into pancreatic beta (insulin-producing) cells. An understanding of this process has implications for the treatment of type 1 diabetes, and a major limitation on research has been the number and quality of available human embryonic stem cell lines. Through private funding from the Howard Hughes Medical Institute and a partnership between the institute, Harvard, and the Boston In Vitro Fertility Clinic, Melton and his colleagues have been able to develop additional embryonic stem cell lines. Melton has testified in Congress against current restrictions on the use of federal funds to support human embryonic stem cell research. He is also working on a method of producing stem cells that does not require human embryos, thereby avoiding some of the controversy in the stem cell debate.

Us Stem Cell Research Policy & Programs Handbook

Us Stem Cell Research Policy & Programs Handbook

US Stem Cell Research Policy & Programs Handbook

List Price: $ 149.95

Price: $ 149.95

Reaction: Stem cell policy shift

What do you think of the presidents decision to lift the ban on federal funding for embryonic stem cell research? Some Republicans have stated that this is largely a distraction from the economy. Do you agree with that statement? What limitations, if any, do you think should be placed on embryonic stem cell research?

Stem Cell Century: Law and Policy for a Breakthrough Technology

Stem Cell Century: Law and Policy for a Breakthrough Technology

The explosion of interest in stem cell research raises a raft of controversial policy questions. When should human embryos be used to create stem cells? Should cloning be outlawed? Should egg and tissue donors be paid? Should we allow scientists to patent stem cells? Is the government entitled to a portion of the revenue from stem cell technology created with public funds? How should the regulators and courts balance the competing goals of access to revolutionary treatments and protection of the public from unknown risks?

Russell Korobkin, with contributions from Stephen R. Munzer, provides the first thorough discussion and analysis of these and other unsettled questions of law, policy, and ethics that surround stem cell science. His clear and concise description of complex problems coupled with logical and well-balanced  conclusions makes this volume essential reading for all Americans, general readers and experts alike, interested in the promise of stem cell research and the future of regenerative medicine.  

Rating: (out of 2 reviews)

List Price: $ 23.00

Price: $ 15.60

Stem Cell Protocols Methods Main Menu